Overview
Yuichi Taneyama practices in Chiba, Japan. Taneyama is rated as an Experienced expert by MediFind in the treatment of Progressive Multifocal Leukoencephalopathy. Their top areas of expertise are Rosai-Dorfman Disease, Acute Lymphoblastic Leukemia (ALL), Acute Monoblastic Leukemia (AmoL), and Leukemoid Reaction.
Their clinical research consists of co-authoring 12 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Progressive Multifocal Leukoencephalopathy.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Rosai-Dorfman DiseaseTaneyama isAdvanced. Learn about Rosai-Dorfman Disease.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Taneyama isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Monoblastic Leukemia (AmoL)Taneyama isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Burkitt LymphomaTaneyama isExperienced. Learn about Burkitt Lymphoma.
- Down SyndromeTaneyama isExperienced. Learn about Down Syndrome.
- HistiocytosisTaneyama isExperienced. Learn about Histiocytosis.
- LeukemiaTaneyama isExperienced. Learn about Leukemia.